Page last updated: 2024-09-03

ak 2123 and Neoplasms

ak 2123 has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aibe, N; Kagiya, T; Kobayashi, K; Kodani, N; Koizumi, M; Nakamura, S; Tsubokura, T; Yamada, K; Yamazaki, H; Yoshida, K	1
Banerjee, S; Chakraborty, S; Das, T; Kagiya, VT; Mukherjee, A; Nair, CK; Samuel, G; Sarma, HD; Venkatesh, M	1
Shibamoto, Y	1
Kothari, L; Murugesan, S; Nair, CK; Noronha, OP; Samuel, AM; Shetty, SJ; Srivastava, TS	1

Reviews

1 review(s) available for ak 2123 and Neoplasms

Article	Year
[Contribution of radiation biology to the development of radiation therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Humans; Imidazoles; Lung Neoplasms; Neoplasms; Nimorazole; Radiation-Sensitizing Agents; Triazoles	1999

Trials

1 trial(s) available for ak 2123 and Neoplasms

Article	Year
Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy. Anticancer research, 2013, Volume: 33, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Radiation-Sensitizing Agents; Triazoles	2013

Other Studies

2 other study(ies) available for ak 2123 and Neoplasms

Article	Year
Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia. Bioorganic & medicinal chemistry, 2004, Dec-01, Volume: 12, Issue:23 Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles	2004
Technetium-99m-cyclam AK 2123: a novel marker for tumor hypoxia. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2001, Volume: 54, Issue:1 Topics: Animals; Cell Hypoxia; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Triazoles	2001

Article

Year

Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.

Bioorganic & medicinal chemistry, 2004, Dec-01, Volume: 12, Issue:23

Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles

2004

Technetium-99m-cyclam AK 2123: a novel marker for tumor hypoxia.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2001, Volume: 54, Issue:1

Topics: Animals; Cell Hypoxia; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Triazoles

2001